G

Grand Pharmaceutical Group Ltd
HKEX:512

Watchlist Manager
Grand Pharmaceutical Group Ltd
HKEX:512
Watchlist
Price: 8.08 HKD -0.98%
Market Cap: 28.7B HKD

Intrinsic Value

The intrinsic value of one Grand Pharmaceutical Group Ltd stock under the Base Case scenario is 6.55 HKD. Compared to the current market price of 8.08 HKD, Grand Pharmaceutical Group Ltd is Overvalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
6.55 HKD
Overvaluation 19%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation History
Grand Pharmaceutical Group Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Grand Pharmaceutical Group Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Grand Pharmaceutical Group Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Grand Pharmaceutical Group Ltd.

Explain Valuation
Compare Grand Pharmaceutical Group Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Grand Pharmaceutical Group Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Grand Pharmaceutical Group Ltd

Current Assets 8B
Cash & Short-Term Investments 1.4B
Receivables 4.6B
Other Current Assets 1.9B
Non-Current Assets 18.4B
Long-Term Investments 8.3B
PP&E 4.4B
Intangibles 4.5B
Other Non-Current Assets 1.2B
Current Liabilities 6.7B
Accounts Payable 5.2B
Accrued Liabilities 2B
Short-Term Debt 2.3m
Other Current Liabilities -495.5m
Non-Current Liabilities 2.6B
Long-Term Debt 1.8B
Other Non-Current Liabilities 794.8m
Efficiency

Free Cash Flow Analysis
Grand Pharmaceutical Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Grand Pharmaceutical Group Ltd

Revenue
11.7B HKD
Cost of Revenue
-5B HKD
Gross Profit
6.7B HKD
Operating Expenses
-4.8B HKD
Operating Income
2B HKD
Other Expenses
103.8m HKD
Net Income
2.1B HKD
Fundamental Scores

Profitability Score
Profitability Due Diligence

Grand Pharmaceutical Group Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Positive 3Y Average ROE
Sustainable 3Y Average Operating Margin
53/100
Profitability
Score

Grand Pharmaceutical Group Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Grand Pharmaceutical Group Ltd's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
High Altman Z-Score
High Interest Coverage
66/100
Solvency
Score

Grand Pharmaceutical Group Ltd's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Grand Pharmaceutical Group Ltd

Wall Street analysts forecast Grand Pharmaceutical Group Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Grand Pharmaceutical Group Ltd is 12.09 HKD with a low forecast of 11.82 HKD and a high forecast of 12.6 HKD.

Lowest
Price Target
11.82 HKD
46% Upside
Average
Price Target
12.09 HKD
50% Upside
Highest
Price Target
12.6 HKD
56% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Grand Pharmaceutical Group Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Grand Pharmaceutical Group Ltd stock?

The intrinsic value of one Grand Pharmaceutical Group Ltd stock under the Base Case scenario is 6.55 HKD.

Is Grand Pharmaceutical Group Ltd stock undervalued or overvalued?

Compared to the current market price of 8.08 HKD, Grand Pharmaceutical Group Ltd is Overvalued by 19%.

Back to Top